Anthony Afum-Adjei Awuah (SCIENTIFIC OFFICER)

Dr. Anthony Afum-Adjei Awuah is a lecturer at the Department of Molecular Medicine at the School of Medicine and Dentistry and postdoctoral research fellow with the Global Health and Infectious Disease Research Group at the Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR), in KNUST. He is an early career researcher with experience in clinical research and community-based studies. He is the lab coordinator for the VAT COVID-19 vaccine trial, Co-Investigator for ANTICOV clinical trial, Principal Investigator for the ANTICOV-IMMUNO study investigating the impact of COVID-19 treatment on the type, strength and duration of antibody and cellular immune responses in SARS-CoV-2 patients in sub-Saharan Africa and Co-PI on the SEROCOV study, investigating the Seroprevalence of COVID-19 in four African countries among others. Anthony started his career with a degree in Biochemistry from the Department of Biochemistry and Biotechnology, KNUST and joined the EOD working group at KCCR to do his PhD in Immunology, investigating the role of immune modulatory molecules in the immunopathogenesis of tuberculosis. After his PhD, he started his postdoc with the same group at KCCR where he developed means
to improve the use of interferon gamma release assay (IGRA) to diagnose TB in children. He has had other postdoc training with Centre Muraz in Burkina through the West Africa Health Research Network and GSK vaccine s.r.l in Siena, Italy through WHO/TDR fellowship grant. He was part of the 2017 cohort of the Next Generation Scientist program to train young emerging scientists in clinical research at the headquarter of Novartis Pharma in Basel. He has extensive experience in the design, planning and conduct of clinical research. His research areas include infectious diseases, immunology, vaccinology and clinical research.